InsidersTradesSigma
Follow the MARRONE BIO INNOVATIONS INC share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Food & Beverage sector, MARRONE BIO INNOVATIONS INC has published 34 public disclosures. The latest transaction was reported on 13 June 2022 (Cession). Among the most active insiders: Marrone Pamela G. All data is openly available.
34
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€171,068
8 ops.
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 June 2022
Declarations34 total
20,492 shares@ US$1.177110.2% of flowCommon StockSEC:0001209191-22-036400:0
21,009 shares@ US$1.14810.1% of flowCommon StockSEC:0001209191-22-031981:0
20,000 shares@ US$0.806.5% of flowCommon StockSEC:0001209191-22-021343:0
79,481 shares@ US$0.632129.2% of flowCommon StockSEC:0001209191-22-020085:0
178,831 shares@ US$0.632124.8% of flowCommon StockSEC:0001209191-22-020079:0
65,064 shares@ US$0.632133.3% of flowCommon StockSEC:0001209191-22-020077:0
111,039 shares@ US$0.632129.6% of flowCommon StockSEC:0001209191-22-020083:0
66,623 shares@ US$0.632129.6% of flowCommon StockSEC:0001209191-22-020081:0
108,312 shares@ US$0.632125.4% of flowCommon StockSEC:0001209191-22-020084:0
79,481 shares@ US$0.632182.5% of flowCommon StockSEC:0001209191-22-008151:0
111,039 shares@ US$0.632184.0% of flowCommon StockSEC:0001209191-22-008146:0
108,312 shares@ US$0.632168.2% of flowCommon StockSEC:0001209191-22-008149:0
65,064 shares@ US$0.6321100.0% of flowCommon StockSEC:0001209191-22-008135:0
178,831 shares@ US$0.632165.9% of flowCommon StockSEC:0001209191-22-008138:0
66,623 shares@ US$0.632184.3% of flowCommon StockSEC:0001209191-22-008143:0
3,553,583 shares@ US$0.75100.0% of flowCommon Stock, $0.00001 par valueSEC:0000899243-21-048765:0
618,014 shares@ US$0.75100.0% of flowCommon StockSEC:0001019056-21-000595:0
30,000 shares@ US$0.809.1% of flowCommon StockSEC:0001209191-21-056635:0
24,510 shares@ US$1.029.6% of flowCommon StockSEC:0001209191-21-053362:0
47,000 shares@ US$1.069928.6% of flowCommon StockSEC:0001209191-21-053129:0
10,000 shares@ US$1.03100.0% of flowCommon StockSEC:0001209191-21-053135:0
2,000 shares@ US$1.0375100.0% of flowCommon StockSEC:0001209191-21-053132:0
17,858 shares@ US$1.459.9% of flowCommon StockSEC:0001493152-21-019230:0
17,858 shares@ US$1.409.5% of flowCommon StockSEC:0001209191-21-048435:0
17,007 shares@ US$1.499.6% of flowCommon StockSEC:0001209191-21-046335:0
25 of 34 declarations
关于 MARRONE BIO INNOVATIONS INC
Marrone Bio Innovations Inc.(MBII)是一家美国农业生物解决方案公司,专注于用于作物保护和植物健康的生物产品。该公司植根于加州戴维斯,这符合其在农学和应用微生物学中的创新概况。对于法国、比利时和瑞士的投资者而言,重要的是要注意MBII是在NASDAQ市场上市的美国公司,在SEC披露框架下运营,并通过Form 4备案受美国内部人交易报告的约束。([sec.gov](https://www.sec.gov/Archives/edgar/data/0001748858/000120919121000351/xslF345X03/doc4.xml?utm_source=openai)) MBII的核心业务围绕发现、开发和商业化生物解决方案,旨在改善作物性能,同时减少对常规化学投入品的依赖。其产品组合包括生物杀菌剂、生物杀虫剂、生物除草剂、生物刺激剂和种子处理解决方案。这将公司置于农业的利基但战略上重要的细分市场:生物作物投入品。这一类别中的竞争差异化通常取决于产品效能、监管接受度、田间表现和融入综合虫害管理计划的能力。因此,MBII的定位反映了一种科学主导的商业模式,与大型农化集团和日益增长的专业生物科学参与者竞争。([sec.gov](https://www.sec.gov/Archives/edgar/data/0001748858/000120919121000351/xslF345X03/doc4.xml?utm_source=openai)) 从地理位置来看,该公司主要以美国为中心,但其商业逻辑本质上是国际性的,因为生物作物投入品可以通过经销商和战略伙伴关系在主要农业地区扩展。MBII不是一个完全整合的全球作物投入品巨头;相反,它是一家较小的、创新驱动的农业生物技术公司,对商业化执行、市场采用周期和资本市场支持有重大依赖。这种概况通常使此类公司比成熟的农业巨头波动性更大,但如果生物产品获得种植者的关注,也更容易获得上升空间。([sec.gov](https://www.sec.gov/Archives/edgar/data/0001748858/000120919121000351/xslF345X03/doc4.xml?utm_source=openai)) 一个关键的近期里程碑是该公司在2022年的控制权变更交易,其中它被纳入Bioceres Crop Solutions。该事件实质性地改变了MBII的独立市场概况,这意味着最近的SEC材料,包括Form 4内部人备案和合并相关披露,对于理解公司的遗留股权故事特别相关。实际上,MBII应被视为一家前美国NASDAQ上市的生物农业创新者,总部位于加州,其历史说明了农业生物技术和生物解决方案中的整合趋势。([sec.gov](https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/xslF345X03/doc4.xml?utm_source=openai))
